外来で診る不明熱

出版社： 中山書店
著者：
発行日： 2017-08-10
分野： 臨床医学：内科  >  内科学一般
ISBN： 9784521745398
電子書籍版： 2017-08-10 （初版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

3,850 円(税込)

購入する
電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

3,850 円(税込)

購入する

商品紹介

総合病院DPC化の今日，外来で不明熱を診ないのは発熱の全景をまだ見ていないと言える．国立国際医療研究センター病院総合診療科では2014年以来，「不明熱外来」を開設し，原因不明の発熱患者を診察している．多くの不明熱患者を診療して見えてきたことは？　“発熱パターン”と“発熱カレンダー”で不明熱を診よう！　『内科で診る不定愁訴』と併せて読んでください．

目次

  • 外来で診る不明熱

    ―目次―

    第1章　不明熱を外来で診る
    　私の不明熱論
    　古典的不明熱の定義の抜け穴
    　外来で診る不明熱患者の一般的傾向
    　入院させることを考慮するとき

    第2章 「不明熱外来」を開いたらこうなった
    　不明熱外来ｎ

    第3章　発熱パターン別「外来で診る不明熱」の診断マトリックス
    　発熱パターンの類型化
    　マトリックスの全貌と注意点
    　反復するということ

    第4章 「発熱カレンダー」で分析しよう
    　　　　外来で診るちょっと難しい不明熱
    　熱が出たり下がったりする不明熱への対応
    「発熱カレンダー」をつくろう

    第5章　外来で遭遇する不明熱
    　　　　5つの臨床的カテゴリー
    　病態別・難易度別　Case-based Learning

    第6章　不明熱を治療する
    　不明熱を診断するのではなく、「治療」する
    　ステロイドで治療する病気
    　コルヒチンで治療する病気
    　機能性高体温症の治療
    　薬物治療中、気をつけること

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1章 不明熱を外来で診る

P.5 掲載の参考文献
1 Petersdorf RG, Beeson PB. Fever of unexplained origin : report on 100 cases. Medicine 1961 : 40 ; 1-30.
PubMed
P.10 掲載の参考文献
1 Petersdorf RG, Beeson PB. Fever of unexplained origin : report on 100 cases. Medicine 1961 : 40 ; 1-30.
PubMed
2 Durack DT, et al. Fever of unknown origin-reexamined and redefined. Curr Clin Top Infect Dis 1991 : 11 ; 35-51.
PubMed
3 國松淳和ら. 外来における不明熱の原因疾患としての家族性地中海熱の重要性. 日本臨床免疫学会会誌. 2016 : 39 ; 130-9.
Medical*Online
4 McDermott MF, Aksentijevich I, Galon J, et al. Germline mutations in the extracellular domains of the 55kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 1999 : 97 : 133-44.
 
P.16 掲載の参考文献
1 山下裕之ら. 不明熱・不明炎症の原因としての悪性リンパ腫の重要性. 日本臨床免疫学会会誌. 2012 : 35 ; 136-43.
Medical*Online
2 Drenth JP, van der Meer JW. Hereditary periodic fever. N Engl J Med 2001 ; 345 : 1748.
PubMed

第2章 「不明熱外来」を開いたらこうなった

P.29 掲載の参考文献
1 國松淳和ら. 外来における不明熱の原因疾患としての家族性地中海熱の重要性. 日本臨床免疫学会会誌 2016 : 39 ; 130-9.
Medical*Online

第3章 発熱パターン別「外来で診る不明熱」の診断マトリックス

P.45 掲載の参考文献
1 Saukkonen K, et al. CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 8-2016. A 71-Year-Old Man with Recurrent Fevers, Hypoxemia, and Lung Infiltrates. N Engl J Med 2016 : 374 ; 1077-85.
PubMed
P.50 掲載の参考文献
1 大曲貴夫, 忽那賢志, 國松淳和, 佐田竜一, 狩野俊和. Fever発熱について我々が語るべき幾つかの事柄. 東京 : 金原出版 ; 2015.
 

第5章 外来で遭遇する不明熱 5つの臨床的カテゴリー

P.99 掲載の参考文献
1 Kucukardali Y, et al. Kikuchi-Fujimoto Disease : analysis of 244 cases. Clin Rheumatol 2007 : 26 ; 50-4.
PubMed
2 Singer JZ, Wallace SL. The allopurinol hypersensitivity syndrome. Unnecessary morbidity and mortality. Arthritis Rheum 1986 : 29 ; 82-7.
PubMed
3 Cunha BA editor. Fever of Unknown Origin (Infections Disease and Therapy). CRC Press ; 2007.
 
P.117 掲載の参考文献
1 山下裕之ら. 不明熱・不明炎症の原因としての悪性リンパ腫の重要性. 日本臨床免疫学会会誌 2012 : 35 ; 136-43.
Medical*Online
P.141 掲載の参考文献
1 Knockaert DC. Recurrent Fevers of Unknown Origin. Infect Dis Clin North Am 2007 : 21 ; 1198.
 
2 Knockaert DC, et al. Recurrent or episodic fever of unknown origin : review of 45 cases and survey of the literature. Medicine (Baltimore) 1993 : 72 ; 184-96.
 
3 Mahmud T, et al. Crystal arthropathy of the lumbar spine : a series of six cases and a review of the literature. J Bone Joint Surg Br 2005 : 87 ; 513-7.
 
4 Lam HY, et al. Crystal arthropathy of the lumbar spine : a report of 4 cases. J Orthop Surg (Hong Kong) 2007 : 15 ; 94-101.
 
P.165 掲載の参考文献
1 Reimann HA. HABITUAL HYPERTHERMIA. JAMA 1932 : 99 (22) ; 1860-2. doi : 10.1001/jama.1932.27410740001012
 
2 Moro E. Habituelle Hyperthermie. Monatschr. f. Kinderh, 1916 : 14 (214) ; 1916-18.
 
3 Petersdorf RG, Beeson PB. Fever of unexplained origin : report on 100 cases. Medicine 1961 : 40 ; 1-30.
PubMed
4 岡孝和. 心因性発熱のメカニズム. 児心身誌 子どもの心とからだ 2014 : 22 ; 295-305.
 
5 Thompson HJ, et al. Neurogenic fever after traumatic brain injury : an epidemiological study. J Neurol Neurosurg Psychiatry 2003 : 74 ; 614-9.
PubMed
P.181 掲載の参考文献
1 Zanger B, Dorsey HN. Fever--a manifestation of preleukemia. JAMA 1976 : 236 ; 1266-8.
 
2 Saif MW, et al. Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia. Leuk Lymphoma 2002 : 43 ; 2083-92.
PubMed
3 Cunha BA, et al. Fever of unknown origin due to preleukemia/myelodysplastic syndrome : the diagnostic importance of monocytosis with elevated serum ferritin levels. Heart Lung 2006 : 35 ; 277-82.
PubMed
4 Lazarus AA, et al. Pulmonary involvement in Sweet's syndrome (acute febrile neutrophilic dermatosis). Preleukemic and leukemic phases of acute myelogenous leukemia. Chest 1986 : 90 ; 922-4.
PubMed
5 Aydemir H, et al. Pulmonary and central nervous system involvement in Sweet's syndrome : a very rare case report. Intern Med 2008 : 47 ; 1481-4.
PubMed

第6章 不明熱を治療する

P.233 掲載の参考文献
1 Bryan CS, Ahuja D. Fever of unknown origin : is there a role for empiric therapy? Infect Dis Clin North Am 2007 Dec ; 21 (4) : 1213-20, xi.
 
2 隈部綾子, 畠山修司. 治療開始2ヶ月後に診断確定した不明熱の1例. Medical Practice 2016 ; 33 : 1321-3.
 
3 Cunha BA. Fever of unknown origin. Infect Dis Clin North Am 1996 ; 10 : 111-27.
PubMed
4 Buttgereit F, Straub RH, Wehling M, Burmester GR. Glucocorticoids in the treatment of rheumatic diseases : an update on the mechanisms of action. Arthritis Rheum 2004 ; 50 (11) : 3408-17.
PubMed
5 Buttgereit F, Burmester GR, Straub RH, Seibel MJ, Zhou H. Exogenous and endogenous glucocorticoids in rheumatic diseases. Arthritis Rheum 2011 Jan ; 63 (1) : 1-9. doi : 10.1002/art.30070.
 
6 Dumas G, et al. Kikuchi-Fujimoto disease : retrospective study of 91 cases and review of the literature. Medicine (Baltimore) 2014 Nov ; 93 (24) : 372-82. doi : 10.1097/MD.0000000000000220.
 
7 Song JY, et al. Clinical outcome and predictive factors of recurrence among patients with Kikuchi's disease. Int J Infect Dis 2009 ; 13 : 322-6.
PubMed
8 Yu H-L, et al. Clinical manifestations of Kikuchi's disease in southern Taiwan. J Microbiol Immunol Infect 2005 ; 38 : 35-40.
PubMed
9 中村造ほか. 菊池病 69例の臨床的検討. 感染症誌 2009 ; 83 (4) : 363-8.
 
10 Schwartz RA, Nervi SJ. Erythema nodosum : a sign of systemic disease. Am Fam Physician 2007 ; 75 (5) : 695-700.
PubMed
11 Sato J, et al. Comparison of the therapeutic effects of prednisolone and nonsteroidal anti-inflammatory drugs in patients with subacute thyroiditis. Endocrine 2016 ; 29. [Epub ahead of print]
 
12 Kubota S, et al. Initial treatment with 15 mg of prednisolone daily is sufficient for most patients with subacute thyroiditis in Japan. Thyroid 2013 ; 23 (3) : 269-72. doi : 10.1089/thy.2012.0459.
 
13 Arao T, et al. Prednisolone Dosing Regimen for Treatment of Subacute Thyroiditis. J UOEH 2015 ; 37 (2) : 103-10. doi : 10.7888/juoeh.37.103.
 
14 Naito T, et al. Diagnostic workup for fever of unknown origin : a multicenter collaborative retrospective study. BMJ Open 2013 ; 20 ; 3 (12) : e003971. doi : 10.1136/bmjopen-2013-003971.
 
15 Takahashi H, et al. Differences in fluorodeoxyglucose positron emission tomography/computed tomography findings between elderly onset rheumatoid arthritis and polymyalgia rheumatica. Mod Rheumatol 2015 ; 25 (4) : 546-51. doi : 10.3109/14397595.2014.978936. Epub 2014 Nov 17.
 
16 Oiwa H. A role of the FDG-PET/CT in the differential diagnosis between elderly onset rheumatoid arthritis and polymyalgia rheumatica ; Comment on the study by Dr. Takahashi et al. Mod Rheumatol 2016 ; 26 (5) : 804. doi : 10.3109/14397595.2015.1072904. Epub 2015 Aug 25.
 
17 Aydeniz A, Altindag O, Ogut E, Gursoy S. Late onset spondyloarthropathy mimicking polymyalgia rheumatica. Rheumatol Int 2012 ; 32 (5) : 1357-8. doi : 10.1007/s00296-010-1394-5. Epub 2010 Mar 18.
 
18 Gonzalez-Gay MA, et al. The spectrum of conditions mimicking polymyalgia rheumatica in Northwestern Spain. J Rheumatol 2000 ; 27 (9) : 2179-84.
 
19 Auzary C, et al. Subacute bacterial endocarditis presenting as polymyalgia rheumatica or giant cell arteritis. Clin Exp Rheumatol. 2006 ; 24 (S41) : S38-40.
PubMed
20 三森明夫. 膠原病臨床ノート (第3版). 日本医事新報社 ; 2013.
 
21 金城光代. リウマチ性多発筋痛症, 巨細胞性動脈炎. Hospitalist 2014 ; 2 (2) : p457.
 
22 Dejaco C, et al. 2015 Recommendations for the management of polymyalgia rheumatica : a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis 2015 ; 74 (10) : 1799-807. doi : 10.1136/annrheumdis-2015-207492.
 
23 Dasgupta B, et al. BSR and BHPR Standards, Guidelines and Audit Working Group. BSR and BHPR guidelines for the management of polymyalgia rheumatica. Rheumatology (Oxford) 2010 ; 4 (9 1) : 186─ 90. doi : 10.1093/rheumatology/kep303a. Epub 2009 Nov 12.
 
24 NHG. NHG-Standaard Polymyalgia rheumatica en arteriitis temporalis. https://www.nhg.org/standaarden/volledig/nhg-standaard-polymyalgia-rheumatica-enarteriitis-temporalis.
 
25 Hernandez-Rodriguez J, et al. Treatment of polymyalgia rheumatica : a systematic review. Arch Intern Med 2009 ; 169 (20) : 1839-50. doi : 10.1001/archinternmed.2009.352.
 
26 Cimmino MA, Parodi M, Montecucco C, Caporali R. The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity. BMC Musculoskelet Disord 2011 ; 12 (1) : 94. doi : 10.1186/1471-2474-12-94.
PubMed
27 Quick V, Kirwan JR. Our approach to the diagnosis and treatment of polymyalgia rheumatica and giant cell (temporal) arteritis. J R Coll Physicians Edinb 2012 ; 42 (4) : 341-9. doi : 10.4997/JRCPE.2012.413.
 
28 Vigo G, Zulian F. Periodic fevers with aphthous stomatitis, pharyngitis, and adenitis (PFAPA). Autoimmun Rev 2012 ; 12 (1) : 52-5. doi : 10.1016/j.autrev.2012.07.021. Epub 2012 Aug 2.
 
29 Theodoropoulou K, Vanoni F, Hofer M. Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome : a Review of the Pathogenesis. Curr Rheumatol Rep 2016 ; 18 (4) : 18. doi : 10.1007/s11926-016-0567-y.
 
30 Terreri MT, et al. Guidelines for the management and treatment of periodic fever syndromes : periodic fever, aphthous stomatitis, pharyngitis and adenitis syndrome. Rev Bras Reumatol Engl Ed 2016 ; 56 (1) : 52-7. doi : 10.1016/j.rbre.2015.09.004. Epub 2015 Oct 20.
 
31 Yazgan H, et al. Comparison of conventional and low dose steroid in the treatment of PFAPA syndrome : preliminary study. Int J Pediatr Otorhinolaryngol 2012 ; 76 (11) : 1588-90. doi : 10.1016/j.ijporl.2012.07.020. Epub 2012 Jul 31.
 
32 Ter Haar N, et al ; Paediatric Rheumatology International Trials Organisation (PRINTO) and the Eurofever/Eurotraps Projects. Treatment of autoinflammatory diseases : results from the Eurofever Registry and a literature review. Ann Rheum Dis 2013 ; 72 (5) : 678-85. doi : 10.1136/annrheumdis-2011-201268. Epub 2012 Jun 29.
 
33 小児慢性特定疾病情報センター. TNF受容体関連周期性症候群 診断の手引き. http://www.shouman.jp/instructions/6_5_17/.
 
34 Ter Haar NM, et al. Recommendations for the management of autoinflammatory diseases. Ann Rheum Dis 2015 ; 74 (9) : 1636-44. doi : 10.1136/annrheumdis-2015-207546. Epub 2015 Jun 24.
 
35 Lachmann HJ, et al. The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation : a series of 158 cases from the Eurofever/EUROTRAPS international registry. Ann Rheum Dis 2014 ; 73 : 2160-7.
PubMed
36 Hull KM, et al. The TNF receptor-associated periodic syndrome (TRAPS) : emerging concepts of an autoinflammatory disorder. Medicine (Baltimore) 2002 ; 81 : 349-68.
PubMed
37 Leung YY, Yao Hui LL, Kraus VB. Colchicine--Update on mechanisms of action and therapeutic uses. Semin Arthritis Rheum 2015 ; 45 (3) : 341-50. doi : 10.1016/j.semarthrit.2015.06.013. Epub 2015 Jun 26.
 
38 Slobodnick A, Shah B, Pillinger MH, Krasnokutsky S. Colchicine : old and new. Am J Med 2015 ; 128 (5) : 461-70. doi : 10.1016/j.amjmed.2014.12.010. Epub 2014 Dec 30.
 
39 Misawa T, et al. Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome. Nat Immunol 2013 ; 14 (5) : 454-60. doi : 10.1038/ni.2550. Epub 2013 Mar 17.
 
40 Ozen S, et al. EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis 2016 ; 75 (4) : 644-51. doi : 10.1136/annrheumdis-2015-208690. Epub 2016 Jan 22.
 
41 Polat A, et al. Comparison of the efficacy of once- and twice-daily colchicine dosage in pediatric patients with familial Mediterranean fever-a randomized controlled noninferiority trial. Arthritis Res Ther 2016 ; 18 : 85. doi : 10.1186/s13075-016-0980-7.
 
42 Yamanaka H. Japanese Society of Gout and Nucleic Acid Metabolism. Japanese guideline for the management of hyperuricemia and gout : second edition. Nucleosides Nucleotides Nucleic Acids 2011 ; 30 (12) : 1018-29. doi : 10.1080/15257770.2011.596496.
 
43 Hamburger M, et al. 2011 Recommendations for the diagnosis and management of gout and hyperuricemia. Postgrad Med 2011 ; 123 (S1) : 3-36.
 
44 Zhang W, et al. EULAR recommendations for calcium pyrophosphate deposition. Part II : management. Ann Rheum Dis 2011 ; 70 (4) : 571-5. doi : 10.1136/ard.2010.139360. Epub 2011 Jan 20.
 
45 Yurdakul S1, et al. A double-blind trial of colchicine in Behcet's syndrome. Arthritis Rheum 2001 ; 44 (11) : 2686-92.
 
46 Hatemi G, et al. Management of Behcet disease : a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behcet disease. Ann Rheum Dis 2009 ; 68 (10) : 1528-34. doi : 10.1136/ard.2008. 087957. Epub 2008 Apr 17.
 
47 Davatchi F, et al. Colchicine versus placebo in Behcet's disease : randomized, double-blind, controlled crossover trial. Mod Rheumatol 2009 ; 19 (5) : 542-9. doi : 10.1007/s10165-009-0200-2. Epub 2009 Jul 14.
 
48 Imazio M, et al. CORP (COlchicine for Recurrent Pericarditis) Investigators. Colchicine for recurrent pericarditis (CORP) : a randomized trial. Ann Intern Med 2011 ; 155 (7) : 409-14. doi : 10.7326/0003-4819-155-7-201110040-00359. Epub 2011 Aug 28.
 
49 Imazio M, et al. ICAP Investigators. A randomized trial of colchicine for acute pericarditis. N Engl J Med 2013 ; 369 (16) : 1522-8. doi : 10.1056/NEJMoa1208536. Epub 2013 Aug 31.
 
50 Imazio M, et al. Rationale and design of the COlchicine for Prevention of the Postpericardiotomy Syndrome and Post-operative Atrial Fibrillation (COPPS-2 trial) : a randomized, placebo-controlled, multicenter study on the use of colchicine for the primary prevention of the postpericardiotomy syndrome, postoperative effusions, and postoperative atrial fibrillation. Am Heart J 2013 ; 166 (1) : 13-9. doi : 10.1016/j.ahj.2013.03.025. Epub 2013 May 6.
 
51 Imazio M, et al. Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2) : a multicentre, double-blind, placebo-controlled, randomised trial. Lancet 2014 ; published online March 30. http://dx.doi.org/10.1016/S0140-6736(13)62709-9.
 
52 Butbul Aviel Y, Tatour S, Gershoni Baruch R, Brik R. Colchicine as a therapeutic option in periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis (PFAPA) syndrome. Semin Arthritis Rheum 2016 ; 45 (4) : 471-4. doi : 10.1016/j.semarthrit.2015.07.005. Epub 2015 Jul 21.
 
53 Dusser P, Hentgen V, Neven B, Kone-Paut I. Is colchicine an effective treatment in periodic fever, aphtous stomatitis, pharyngitis, cervical adenitis (PFAPA) syndrome? Joint Bone Spine 2016 ; 83 (4) : 406-11. doi : 10.1016/j.jbspin.2015.08.017. Epub 2016 Apr 7.
 
54 加島雅之. さまよえる「熱」の変遷 (その2) 清熱の方法と意義の変遷. 中医臨床 2013 ; 34 : 44-8.
Medical*Online
55 岡佳恵, 岡孝和. 漢方治療を試みた心因性発熱の一例. 日本東洋医学雑誌 1990 ; 41 : 87-9.
 
56 Leonard BE. Extending the clinical use of anti-depressants. In : Differntial Effects of Antidepressants, Leonard BE et al (eds), Martin Dunitz, London, 1999. pp.81-90
 
57 小山司, 山内美紀. 抗うつ薬の合理的併用療法を考える モノアミン仮説からの検証. Depression Strategy 2012 ; 2 : 1-6.
Medical*Online
58 岡孝和. 心因性発熱のメカニズム. 子どもの心とからだ 2014 ; 22 : 295-305.
Medical*Online
59 Thompson HJ, et al. Hyperthermia following traumatic brain injury : a critical evaluation. Neurobiol Dis 2003 ; 12 (3) : 163-73.
PubMed
60 Thompson HJ, Pinto-Martin J, Bullock MR. Neurogenic fever after traumatic brain injury : an epidemiological study. J Neurol Neurosurg Psychiatry 2003 ; 74 (5) : 614-9.
PubMed
61 Maki M, et al. Significant response to amantadine in a patient with malignant catatonia : A case report. European Psychiatry 2016 ; 33 : 410.
 
62 Northoff G, et al. Therapeutic efficacy of N-methyl D-aspartate antagonist amantadine in febrile catatonia. J Clin Psychopharmacol 1999 ; 19 (5) : 484-6.
 
63 Ene-Stroescu V, Nguyen T, Waiblinger BE. Excellent response to amantadine in a patient with bipolar disorder and catatonia. J Neuropsychiatry Clin Neurosci 2014 ; 26 (1) : E43. doi : 10.1176/appi.neuropsych.13020038.
 
64 Hervey WM, Stewart JT, Catalano G. Treatment of catatonia with amantadine. Clin Neuropharmacol 2012 ; 35 (2) : 86-7. doi : 10.1097/WNF.0b013e318246ad34.
 
65 Salam SA, Kilzieh N. Lorazepam treatment of psychogenic catatonia : an update. J Clin Psychiatry 1988 ; 49 (Sl) : 16-21.
 
66 坪敏仁ほか. 低体温療法後の中枢性発熱に対する黄連解毒湯の効果. 日本東洋医学雑誌 2013 ; 64 : 212-5.
 
67 岡孝和. 【不明熱を切る】 専門医が不明熱を切る 心療内科専門医が不明熱を切る. Modern Physician 2016 ; 36 : 341-5.
 

書評

最近チェックした商品履歴

Loading...